Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: IO Biotech(IOBT) the EBIT is -19.36 M (+26.97%);the EPS is -0.125 (+65.67%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.02B26.97%
----
----
EPS
-0.125265.67%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf